These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 11165111)
1. Changes in strategies for optimal antibacterial therapy in cystic fibrosis. Ratjen F Int J Antimicrob Agents; 2001 Feb; 17(2):93-6. PubMed ID: 11165111 [TBL] [Abstract][Full Text] [Related]
2. The approach to Pseudomonas aeruginosa in cystic fibrosis. Bendiak GN; Ratjen F Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546 [TBL] [Abstract][Full Text] [Related]
3. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D; Stableforth D Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [TBL] [Abstract][Full Text] [Related]
4. Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful? Wilson P; Lambert C; Carr SB; Pao C J Cyst Fibros; 2014 Jul; 13(4):449-54. PubMed ID: 24713592 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Langton Hewer SC; Smyth AR Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321 [TBL] [Abstract][Full Text] [Related]
14. Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis. Stockmann C; Hillyard B; Ampofo K; Spigarelli MG; Sherwin CM Expert Rev Respir Med; 2015 Feb; 9(1):13-22. PubMed ID: 25417708 [TBL] [Abstract][Full Text] [Related]
15. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Taccetti G; Campana S; Festini F; Mascherini M; Döring G Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary infection in mild variant cystic fibrosis: implications for care. Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904 [TBL] [Abstract][Full Text] [Related]
17. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis. Hansen C; Skov M Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692 [TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study. Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453 [TBL] [Abstract][Full Text] [Related]
19. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations. Al-Aloul M; Nazareth D; Walshaw M J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy. Levy J Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]